Fischer, KD
'Beifang' im lateinischen OribasiosGalenos. Bd. 12. 2018 S. 63-74
Sedlaczek, S; Quittkat, C; Amler, N et al.
‘Gesund arbeiten in Thüringen‘. Schnittstelle zwischen Prävention und Kuration - Ergebnisse der Befragung von Thüringer Ärzten im Rahmen des Modellprojektes nach § 20 g SGB VArbeitsmedizin Sozialmedizin Umweltmedizin. Bd. 53. H. 9. 2018 S. 588 - 591
Sedlaczek, S
„Prävention durch Betriebliches Eingliederungsmanagement (BEM)“2018
Thalman, Carine; Horta, Guilherme; Qiao, Lianyong et al.
( Synaptic phospholipids as a new target for cortical hyperexcitability and E/I balance in psychiatric disorders)MOLECULAR PSYCHIATRY. Bd. 23. H. 8. 2018 S. 1699-1710
Hernandez, Pedro; Gronke, Konrad; Diefenbach, Andreas
A catch-22: Interleukin-22 and cancerEUROPEAN JOURNAL OF IMMUNOLOGY. Bd. 48. H. 1. 2018 S. 15-31
Hartmann, Jessica; Muench, Robert C.; Freiling, Ruth-Therese et al.
A Library-Based Screening Strategy for the Identification of DARPins as Ligands for Receptor-Targeted AAV and Lentiviral VectorsMOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT. Bd. 10. 2018 S. 128-143
Zaini, Mohamad A.; Mueller, Christine; de Jong, Tristan V. et al.
A p300 and SIRT1 Regulated Acetylation Switch of C/EBP alpha Controls Mitochondrial FunctionCELL REPORTS. Bd. 22. H. 2. 2018 S. 497-511
Almeida, Francisca F.; Tognarelli, Sara; Marcais, Antoine et al.
A point mutation in the Ncr1 signal peptide impairs the development of innate lymphoid cell subsetsONCOIMMUNOLOGY. Bd. 7. H. 10. 2018
Neitzel, C.; Stroh, S.; Nagel, G. et al.
A promising building block in the chemotherapy of colorectal cancer: The first-in-class mitochondrial disruptor CPI-613NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 391. 2018 S. S58-S58
Glaffig, Markus; Stergiou, Natascha; Hartmann, Sebastian et al.
A Synthetic MUC1 Anticancer Vaccine Containing Mannose Ligands for Targeting Macrophages and Dendritic CellsCHEMMEDCHEM. Bd. 13. H. 1. 2018 S. 25-29